R0.6C transmission blocking vaccine

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameR0.6C transmission blocking vaccine
Drug Alias NamePfs48/45/PfGLURP-bound malaria transmission blocking vaccine (Alhydrogel/Matrix-M1-adjuvanted) (Radboud University/Statens Serum Institut/Novavax)R0.6C malaria transmission blocking vaccine (Radboud University/Statens Serum Institut/Novavax)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAfricaNetherlandsSouth Africa
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRadboud University
China Registration ClassN/A

Develop Information

Active CompaniesRadboud UniversityStatens Serum InstitutNovavax Inc +[4] 
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A